Industry: Pharmaceuticals, Biotechnology
Nyxis Neurotherapies is a privately-held, research-driven biotechnology company focused on the discovery, development and commercialization of therapeutics to treat a wide variety of neurological conditions. Nyxis Neurotherapies uses a proprietary, monoclonal antibody-derived custom peptide (MADCP) technology platform to produce highly-targeted neuro-therapeutic compounds. Headquartered in Chicago, Nyxis Neurotherapies is affiliated with both Northwestern University’s I-Tech Center and its biomedical engineering department’s Falk Center for Molecular Therapeutics. ( www.nyxis.com )
Nyxis Neurotherapies Inc
1801 Maple Ave.
Evanston, Illinois 60208
USA
Tel: (847) 491-4802